Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion type Assertion NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_head.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion description "[Measurement of aortic atherosclerosis 1 mo after adenoviral infusion demonstrated a marked reduction in the mean lesion area of mice infused with rAdv.apoE (58 +/- 8 x 10(3) microns2) when compared with control mice infused with rAdv.luc (161 +/- 10 x 10(3) microns2; P < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_provenance.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion evidence source_evidence_literature NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_provenance.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion SIO_000772 7657831 NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_provenance.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion wasDerivedFrom befree-2016 NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_provenance.
- NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_assertion wasGeneratedBy ECO_0000203 NP1316817.RAGtgl3r7bAC0bEmP_XpsfubOR4vpiN0xb0l4WL-LHsFM130_provenance.